Cargando…
Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma
BACKGROUND: Teniposide (VM-26) has been widely used in the treatment of small cell lung cancer, malignant lymphoma, breast cancer, etc. However, there are few reports on VM-26 against oral cancers. The present study was designed to identify the effect of VM-26 against oral squamous cell carcinoma in...
Autores principales: | Li, Jinzhong, Chen, Wantao, Zhang, Ping, Li, Ningyi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1543631/ https://www.ncbi.nlm.nih.gov/pubmed/16822322 http://dx.doi.org/10.1186/1477-7819-4-41 |
Ejemplares similares
-
Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia
por: Chang, Linlin, et al.
Publicado: (2015) -
Computerized cyclic voltammetric detection
after HPLC of the antineoplastic agents
etoposide, teniposide, adriamycin and its
metabolite adriamycinol in urine samples
por: Ploegmakers, H. H. J. L., et al.
Publicado: (1989) -
Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II
por: Le, Tung T., et al.
Publicado: (2023) -
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
por: Sun, Yan-chang, et al.
Publicado: (2014) -
Patients treatment with neuroglioma by teniposide and semustine and its influence on Twist and E-cadherin expression
por: Zhang, Yongbo, et al.
Publicado: (2016)